BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo C, Liu S, Sun M. Potential role of Anxa1 in cancer. Future Oncology 2013;9:1773-93. [DOI: 10.2217/fon.13.114] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Sabran A, Kumolosasi E, Jantan I. Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines. Acta Pharm 2019;69:75-86. [PMID: 31259717 DOI: 10.2478/acph-2019-0005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Novizio N, Belvedere R, Pessolano E, Tosco A, Porta A, Perretti M, Campiglia P, Filippelli A, Petrella A. Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors. Cells 2020;9:E2719. [PMID: 33353163 DOI: 10.3390/cells9122719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Takaoka RTC, Sertório ND, Magalini LPJ, Dos Santos LM, Souza HR, Iyomasa-Pilon MM, Possebon L, Costa SS, Girol AP. Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias. Pathol Res Pract 2018;214:181-6. [PMID: 29254791 DOI: 10.1016/j.prp.2017.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Vidotto A, Polachini GM, de Paula-Silva M, Oliani SM, Henrique T, López RVM, Cury PM, Nunes FD, Góis-Filho JF, de Carvalho MB, Leopoldino AM, Tajara EH. Differentially expressed proteins in positive versus negative HNSCC lymph nodes. BMC Med Genomics 2018;11:73. [PMID: 30157864 DOI: 10.1186/s12920-018-0382-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li L, Wang Z, Lu T, Li Y, Pan M, Yu D, Hu G. Expression and Functional Relevance of ANXA1 in Hypopharyngeal Carcinoma with Lymph Node Metastasis. Onco Targets Ther 2021;14:1387-99. [PMID: 33658802 DOI: 10.2147/OTT.S292287] [Reference Citation Analysis]
6 Tovar I, Guerrero R, López-Peñalver JJ, Expósito J, Ruiz de Almodóvar JM. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome. Cells 2020;9:E2015. [PMID: 32887260 DOI: 10.3390/cells9092015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
7 Cardin LT, Prates J, da Cunha BR, Tajara EH, Oliani SM, Rodrigues-Lisoni FC. Annexin A1 peptide and endothelial cell-conditioned medium modulate cervical tumorigenesis. FEBS Open Bio 2019;9:668-81. [PMID: 30984541 DOI: 10.1002/2211-5463.12603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Luo S, Xie C, Wu P, He J, Tang Y, Xu J, Zhao S. Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer. Exp Ther Med. 2017;14:6113-6118. [PMID: 29285166 DOI: 10.3892/etm.2017.5298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
9 Flodrova D, Toporova L, Lastovickova M, Macejova D, Hunakova L, Brtko J, Bobalova J. Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicology Letters 2017;281:26-34. [DOI: 10.1016/j.toxlet.2017.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Yang T, Lei J, Feng Q, Song D, Wang X, Gurzu S. Dissection of Immune Profiles in Microsatellite Stable and Low Microsatellite Instability Colon Adenocarcinoma by Multiomics Data Analysis. Journal of Oncology 2022;2022:1-20. [DOI: 10.1155/2022/8588164] [Reference Citation Analysis]
11 Stetson LC, Ostrom QT, Schlatzer D, Liao P, Devine K, Waite K, Couce ME, Harris PLR, Kerstetter-Fogle A, Berens ME, Sloan AE, Islam MM, Rajaratnam V, Mirza SP, Chance MR, Barnholtz-Sloan JS. Proteins inform survival-based differences in patients with glioblastoma. Neurooncol Adv 2020;2:vdaa039. [PMID: 32642694 DOI: 10.1093/noajnl/vdaa039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yeh CC, Hsu CH, Shao YY, Ho WC, Tsai MH, Feng WC, Chow LP. Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer. Mol Cell Proteomics. 2015;14:1527-1545. [PMID: 25850433 DOI: 10.1074/mcp.m114.046417] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
13 Tang L, Chen Y, Chen H, Jiang P, Yan L, Mo D, Tang X, Yan F. DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1. Front Oncol 2020;10:280. [PMID: 32226772 DOI: 10.3389/fonc.2020.00280] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
14 Wei B, Guo C, Liu S, Sun MZ. Annexin A4 and cancer. Clin Chim Acta 2015;447:72-8. [PMID: 26048190 DOI: 10.1016/j.cca.2015.05.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zhang D, Wang W, Zhou H, Su L, Han X, Zhang X, Han W, Wang Y, Xue X. ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma. Front Genet 2022;13:851505. [PMID: 35711921 DOI: 10.3389/fgene.2022.851505] [Reference Citation Analysis]
16 Bizzarro V, Belvedere R, Milone MR, Pucci B, Lombardi R, Bruzzese F, Popolo A, Parente L, Budillon A, Petrella A. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid. Oncotarget. 2015;6:25076-25092. [PMID: 26312765 DOI: 10.18632/oncotarget.4725] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
17 Fang Y, Guan X, Cai T, Long J, Wang H, Xie X, Zhang Y. Knockdown of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro. Mol Med Rep. 2016;13:3858-3866. [PMID: 27035116 DOI: 10.3892/mmr.2016.5022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
18 Brisdelli F, Di Francesco L, Giorgi A, Lizzi AR, Luzi C, Mignogna G, Bozzi A, Schininà ME. Proteomic Analysis of Quercetin-Treated K562 Cells. Int J Mol Sci 2019;21:E32. [PMID: 31861640 DOI: 10.3390/ijms21010032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Chen P, Min J, Wu H, Zhang H, Wang C, Tan G, Zhang F. Annexin A1 is a potential biomarker of bone metastasis in small cell lung cancer. Oncol Lett 2021;21:141. [PMID: 33552260 DOI: 10.3892/ol.2020.12402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Belvedere R, Bizzarro V, Popolo A, Dal Piaz F, Vasaturo M, Picardi P, Parente L, Petrella A. Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells. BMC Cancer 2014;14:961. [PMID: 25510623 DOI: 10.1186/1471-2407-14-961] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
21 Shin J, Song I, Pak JH, Jang S. Upregulation of annexin A1 expression by butyrate in human melanoma cells induces invasion by inhibiting E-cadherin expression. Tumor Biol 2016;37:14577-84. [DOI: 10.1007/s13277-016-5306-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
22 Shi F, Li X, Ma Z, Luan T, Zhong T, Gu Y. Label-Free Quantitative Comparison of Cervical Mucus Peptides in Subjects With Endocervical Adenocarcinoma and Adenocarcinoma in Situ. Technol Cancer Res Treat 2021;20:1533033821997825. [PMID: 33612089 DOI: 10.1177/1533033821997825] [Reference Citation Analysis]
23 Ahmet DS, Basheer HA, Salem A, Lu D, Aghamohammadi A, Weyerhäuser P, Bordiga A, Almeniawi J, Rashid S, Cooper PA, Shnyder SD, Vinader V, Afarinkia K. Application of small molecule FPR1 antagonists in the treatment of cancers. Sci Rep 2020;10:17249. [PMID: 33057069 DOI: 10.1038/s41598-020-74350-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Silva-Oliveira R, Pereira FF, Petronilho S, Martins AT, Lameirinhas A, Constâncio V, Caldas-Ribeiro I, Salta S, Lopes P, Antunes L, Castro F, de Sousa SP, Henrique R, Jerónimo C. Clinical Significance of ARID1A and ANXA1 in HER-2 Positive Breast Cancer. J Clin Med 2020;9:E3911. [PMID: 33276477 DOI: 10.3390/jcm9123911] [Reference Citation Analysis]
25 Huang L, Liao L, Wan Y, Cheng A, Li M, Chen S, Li M, Tan X, Zeng G. Downregulation of Annexin A1 is correlated with radioresistance in nasopharyngeal carcinoma. Oncol Lett 2016;12:5229-34. [PMID: 28101240 DOI: 10.3892/ol.2016.5324] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
26 Lin Y, Lin G, Fang W, Zhu H, Chu K. Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Med Oncol 2014;31:327. [PMID: 25412936 DOI: 10.1007/s12032-014-0327-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
27 Starodubtseva NL, Brzhozovskiy AG, Bugrova AE, Kononikhin AS, Indeykina MI, Gusakov KI, Chagovets VV, Nazarova NM, Frankevich VE, Sukhikh GT, Nikolaev EN. Label-free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation. J Mass Spectrom 2019;54:693-703. [PMID: 31116903 DOI: 10.1002/jms.4374] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
28 Belvedere R, Morretta E, Novizio N, Morello S, Bruno O, Brullo C, Petrella A. The Pyrazolyl-Urea Gege3 Inhibits the Activity of ANXA1 in the Angiogenesis Induced by the Pancreatic Cancer Derived EVs. Biomolecules 2021;11:1758. [PMID: 34944403 DOI: 10.3390/biom11121758] [Reference Citation Analysis]
29 Pouliquen DL, Boissard A, Coqueret O, Guette C. Biomarkers of tumor invasiveness in proteomics (Review). Int J Oncol 2020;57:409-32. [PMID: 32468071 DOI: 10.3892/ijo.2020.5075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 Elíes J, Yáñez M, Pereira TMC, Gil-Longo J, MacDougall DA, Campos-Toimil M. An Update to Calcium Binding Proteins. Adv Exp Med Biol 2020;1131:183-213. [PMID: 31646511 DOI: 10.1007/978-3-030-12457-1_8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
31 Zhu X, Shi G, Lu J, Qian X, Wang D. Potential regulatory mechanism of TNF-α/TNFR1/ANXA1 in glioma cells and its role in glioma cell proliferation. Open Life Sciences 2022;17:208-20. [DOI: 10.1515/biol-2022-0023] [Reference Citation Analysis]
32 Yuzhalin AE, Lim SY, Gordon-Weeks AN, Fischer R, Kessler BM, Yu D, Muschel RJ. Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases. Am J Physiol Gastrointest Liver Physiol 2019;317:G625-39. [PMID: 31545917 DOI: 10.1152/ajpgi.00014.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Pena-Alonso E, Rodrigo JP, Morgan RO, Granda-Díaz R, Salom C, Fernandez MP, García-Pedrero JM. Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b. Sci Rep 2017;7:6790. [PMID: 28754915 DOI: 10.1038/s41598-017-07169-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
34 Boudhraa Z, Merle C, Mazzocut D, Chezal JM, Chambon C, Miot-Noirault E, Theisen M, Bouchon B, Degoul F. Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma. Arch Dermatol Res 2014;306:903-14. [PMID: 25362540 DOI: 10.1007/s00403-014-1517-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
35 Lai T, Li Y, Mai Z, Wen X, Lv Y, Xie Z, Lv Q, Chen M, Wu D, Wu B. Annexin A1 is elevated in patients with COPD and affects lung fibroblast function. Int J Chron Obstruct Pulmon Dis 2018;13:473-86. [PMID: 29440885 DOI: 10.2147/COPD.S149766] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
36 Carels N, Tilli T, Tuszynski JA. A computational strategy to select optimized protein targets for drug development toward the control of cancer diseases. PLoS One 2015;10:e0115054. [PMID: 25625699 DOI: 10.1371/journal.pone.0115054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
37 Pourdavoud P, Pakzad B, Mosallaei M, Saadatian Z, Esmaeilzadeh E, Alimolaie A, Shaygannejad A. MiR-196: emerging of a new potential therapeutic target and biomarker in colorectal cancer. Mol Biol Rep 2020;47:9913-20. [PMID: 33130965 DOI: 10.1007/s11033-020-05949-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sabran A, Kumolosasi E, Jantan I, Jamal JA, Azmi N, Jasamai M. Induction of cell death and modulation of Annexin A1 by phytoestrogens in human leukemic cell lines. Saudi Pharm J 2021;29:73-84. [PMID: 33603542 DOI: 10.1016/j.jsps.2020.12.011] [Reference Citation Analysis]
39 Jia C, Kong D, Guo Y, Li L, Quan L. Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo. Biochem Biophys Res Commun 2018;505:720-5. [PMID: 30292410 DOI: 10.1016/j.bbrc.2018.09.140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Sobral-Leite M, Wesseling J, Smit VT, Nevanlinna H, van Miltenburg MH, Sanders J, Hofland I, Blows FM, Coulson P, Patrycja G, Schellens JH, Fagerholm R, Heikkilä P, Aittomäki K, Blomqvist C, Provenzano E, Ali HR, Figueroa J, Sherman M, Lissowska J, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Phillips KA, Couch FJ, Olson JE, Vachon C, Visscher D, Brenner H, Butterbach K, Arndt V, Holleczek B, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, van de Water B, Broeks A, Chang-Claude J, Chenevix-Trench G, Easton DF, Pharoah PD, García-Closas M, de Graauw M, Schmidt MK; kConFab/AOCS Investigators. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis. BMC Med 2015;13:156. [PMID: 26137966 DOI: 10.1186/s12916-015-0392-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
41 Guo C, Li N, Dong C, Wang L, Li Z, Liu Q, Ma Q, Greenaway FT, Tian Y, Hao L, Liu S, Sun MZ. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis via modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways. J Adv Res 2021;30:85-102. [PMID: 34026289 DOI: 10.1016/j.jare.2020.11.003] [Reference Citation Analysis]
42 Souza HR, de Azevedo LR, Possebon L, Costa SS, Iyomasa-Pilon MM, Oliani SM, Girol AP. Heterogeneity of mast cells and expression of Annexin A1 protein in a second degree burn model with silver sulfadiazine treatment. PLoS One 2017;12:e0173417. [PMID: 28278234 DOI: 10.1371/journal.pone.0173417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
43 Farias VA, Tovar I, Del Moral R, O'Valle F, Expósito J, Oliver FJ, Ruiz de Almodóvar JM. Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes. Front Oncol 2019;9:1381. [PMID: 31970082 DOI: 10.3389/fonc.2019.01381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
44 Anjum S, Sahar T, Nigam A, Wajid S. Transcriptome Analysis of mRNA in Uterine Leiomyoma Using Next-generation RNA Sequencing. ACAMC 2019;19:1703-18. [DOI: 10.2174/1871520619666190409102855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Boudhraa Z, Bouchon B, Viallard C, D'Incan M, Degoul F. Annexin A1 localization and its relevance to cancer. Clin Sci (Lond) 2016;130:205-20. [PMID: 26769657 DOI: 10.1042/CS20150415] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
46 Pessolano E, Belvedere R, Bizzarro V, Franco P, Marco I, Porta A, Tosco A, Parente L, Perretti M, Petrella A. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System. Int J Mol Sci 2018;19:E3878. [PMID: 30518142 DOI: 10.3390/ijms19123878] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
47 Tu Y, Johnstone CN, Stewart AG. Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes. Pharmacol Res 2017;119:278-88. [PMID: 28212890 DOI: 10.1016/j.phrs.2017.02.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
48 Neamtu AA, Maghiar TA, Alaya A, Olah NK, Turcus V, Pelea D, Totolici BD, Neamtu C, Maghiar AM, Mathe E. A Comprehensive View on the Quercetin Impact on Colorectal Cancer. Molecules 2022;27:1873. [PMID: 35335239 DOI: 10.3390/molecules27061873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Han G, Lu K, Huang J, Ye J, Dai S, Ye Y, Zhang L. Effect of Annexin A1 gene on the proliferation and invasion of esophageal squamous cell carcinoma cells and its regulatory mechanisms. Int J Mol Med 2017;39:357-63. [PMID: 28035369 DOI: 10.3892/ijmm.2016.2840] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
50 Chen R, Chen C, Han N, Guo W, Deng H, Wang Y, Ding Y, Zhang M. Annexin-1 is an oncogene in glioblastoma and causes tumour immune escape through the indirect upregulation of interleukin-8. J Cell Mol Med 2022. [PMID: 35770335 DOI: 10.1111/jcmm.17458] [Reference Citation Analysis]
51 Erin N, Ogan N, Yerlikaya A. Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer. Breast Cancer Res Treat 2018;170:235-50. [PMID: 29557524 DOI: 10.1007/s10549-018-4752-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
52 Wan YM, Tian J, Qi L, Liu LM, Xu N. ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma. Exp Ther Med 2017;14:5214-8. [PMID: 29201239 DOI: 10.3892/etm.2017.5148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
53 Macklin R, Wang H, Loo D, Martin S, Cumming A, Cai N, Lane R, Ponce NS, Topkas E, Inder K, Saunders NA, Endo-Munoz L. Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones. Oncotarget 2016;7:43570-87. [PMID: 27259278 DOI: 10.18632/oncotarget.9781] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
54 Dadar M, Shahali Y, Chakraborty S, Prasad M, Tahoori F, Tiwari R, Dhama K. Antiinflammatory peptides: current knowledge and promising prospects. Inflamm Res 2019;68:125-45. [PMID: 30560372 DOI: 10.1007/s00011-018-1208-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
55 Wang ZQ, Faddaoui A, Bachvarova M, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Guillemette C, Gobeil S, Macdonald E. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism. Oncotarget. 2015;6:31522-31543. [PMID: 26372729 DOI: 10.18632/oncotarget.5159] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
56 Sheikh MH, Solito E. Annexin A1: Uncovering the Many Talents of an Old Protein. Int J Mol Sci 2018;19:E1045. [PMID: 29614751 DOI: 10.3390/ijms19041045] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 14.5] [Reference Citation Analysis]
57 Bhardwaj A, Ganesan N, Tachibana K, Rajapakshe K, Albarracin CT, Gunaratne PH, Coarfa C, Bedrosian I. Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling. PLoS One 2015;10:e0127678. [PMID: 26000884 DOI: 10.1371/journal.pone.0127678] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
58 Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, Dalerba P, Wang TC, Han YW. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. EMBO Rep 2019;20:e47638. [PMID: 30833345 DOI: 10.15252/embr.201847638] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 25.7] [Reference Citation Analysis]
59 Tejada-Martinez D, de Magalhães JP, Opazo JC. Positive selection and gene duplications in tumour suppressor genes reveal clues about how cetaceans resist cancer. Proc Biol Sci 2021;288:20202592. [PMID: 33622125 DOI: 10.1098/rspb.2020.2592] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
60 Piras G, Rattazzi L, Paschalidis N, Oggero S, Berti G, Ono M, Bellia F, D'Addario C, Dell'Osso B, Pariante CM, Perretti M, D'Acquisto F. Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cells. Brain Behav Immun 2020;87:689-702. [PMID: 32126289 DOI: 10.1016/j.bbi.2020.02.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Liu Y, Liu Y, Wu P, Li Q, Dai W, Yuan S, Xu Z, Liu T, Miao Z, Fang W, Chen Y, Li B. Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis. The International Journal of Biochemistry & Cell Biology 2015;66:11-9. [DOI: 10.1016/j.biocel.2015.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
62 Guan Y, Li T, Zhang H, Zhu F, Omenn GS. Prioritizing predictive biomarkers for gene essentiality in cancer cells with mRNA expression data and DNA copy number profile. Bioinformatics 2018;34:3975-82. [PMID: 29912344 DOI: 10.1093/bioinformatics/bty467] [Reference Citation Analysis]
63 Manai M, Doghri R, Finetti P, Mrad K, Bouabsa R, Manai M, Birnbaum D, Bertucci F, Charfi L, Driss M. Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer. In Vivo 2020;34:177-84. [PMID: 31882477 DOI: 10.21873/invivo.11759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
64 Ibrahim AA, Ramadan A, Wahby AA, Draz IH, El Baroudy NR, Abdel Hamid TA. Evaluation of miR-196a2 expression and Annexin A1 level in children with bronchial asthmaEvaluation of miR-196a2 expression and Annexin A1 level in children. Allergol Immunopathol (Madr) 2020;48:458-64. [PMID: 32279913 DOI: 10.1016/j.aller.2019.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Stetson LC, Balasubramanian D, Ribeiro SP, Stefan T, Gupta K, Xu X, Fourati S, Roe A, Jackson Z, Schauner R, Sharma A, Tamilselvan B, Li S, de Lima M, Hwang TH, Balderas R, Saunthararajah Y, Maciejewski J, LaFramboise T, Barnholtz-Sloan JS, Sekaly RP, Wald DN. Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression. Leukemia 2021. [PMID: 34244611 DOI: 10.1038/s41375-021-01338-7] [Reference Citation Analysis]
66 Lee SH, Lee PH, Kim BG, Seo HJ, Baek AR, Park JS, Lee JH, Park SW, Kim DJ, Park CS, Jang AS. Annexin A1 in plasma from patients with bronchial asthma: its association with lung function. BMC Pulm Med 2018;18:1. [PMID: 29301525 DOI: 10.1186/s12890-017-0557-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
67 Li D, Hao X, Song Y. Identification of the Key MicroRNAs and the miRNA-mRNA Regulatory Pathways in Prostate Cancer by Bioinformatics Methods. Biomed Res Int 2018;2018:6204128. [PMID: 30027097 DOI: 10.1155/2018/6204128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
68 Tadei MB, Mayorquim MV, de Souza CB, de Souza Costa S, Possebon L, Souza HR, Iyomasa-Pilon MM, Geromel MR, Girol AP. Expression of the Annexin A1 and its correlation with matrix metalloproteinases and the receptor for formylated peptide-2 in diffuse astrocytic tumors. Ann Diagn Pathol 2018;37:62-6. [PMID: 30286327 DOI: 10.1016/j.anndiagpath.2018.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
69 Baracco EE, Petrazzuolo A, Kroemer G. Assessment of annexin A1 release during immunogenic cell death. Methods Enzymol 2019;629:71-9. [PMID: 31727257 DOI: 10.1016/bs.mie.2019.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Gajbhiye A, Dabhi R, Taunk K, Vannuruswamy G, Roychoudhury S, Adhav R, Seal S, Mane A, Bayatigeri S, Santra MK, Chaudhury K, Rapole S. Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics. Proteomics 2016;16:2403-18. [DOI: 10.1002/pmic.201600015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
71 Tang F, Li Z, Lai Y, Lu Z, Lei H, He C, He Z. A 7-gene signature predicts the prognosis of patients with bladder cancer. BMC Urol 2022;22. [DOI: 10.1186/s12894-022-00955-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Liao L, Yan WJ, Tian CM, Li MY, Tian YQ, Zeng GQ. Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma. Technol Cancer Res Treat 2018;17:1533034617750309. [PMID: 29357787 DOI: 10.1177/1533034617750309] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
73 Xiao Y, Ouyang C, Huang W, Tang Y, Fu W, Cheng A. Annexin A1 can inhibit the in vitro invasive ability of nasopharyngeal carcinoma cells possibly through Annexin A1/S100A9/Vimentin interaction. PLoS One 2017;12:e0174383. [PMID: 28355254 DOI: 10.1371/journal.pone.0174383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
74 Shao G, Zhou H, Zhang Q, Jin Y, Fu C. Advancements of Annexin A1 in inflammation and tumorigenesis. Onco Targets Ther 2019;12:3245-54. [PMID: 31118675 DOI: 10.2147/OTT.S202271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
75 Chuang MC, Lung JH, Chen YC, Lin YC, Li YC, Hung MS. The Association of Annexin A1 and Chemosensitivity to Osimertinib in Lung Cancer Cells. Cancers (Basel) 2021;13:4106. [PMID: 34439260 DOI: 10.3390/cancers13164106] [Reference Citation Analysis]